PSNL 3.3 (-7.3%)
US71535D1063• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. PSNL

Personalis (PSNL) Competitor Comparison

We are evaluating the key criteria listed to compare Personalis (PSNL) against its competitors in the Diagnostics & Research industry.

Market Capitalization

46 / 58

Gross Profits

47 / 52

Total Revenue

40 / 57

EBITDA

50 / 56

Free Cashflow

50 / 56

Quick Ratio

17 / 57

Earnings per Share

39 / 56

Dividend yield

0 / 9

Total Cash

32 / 57

Performance 3 years

35 / 58

Performance 5 years

35 / 58

Performance 10 years

46 / 58

Linearity 3 years

38 / 58

Linearity 5 years

20 / 58

Linearity 10 years

34 / 57

Total Rank

55 / 58

Dividend Rank

29 / 58

Valuation Rank

34 / 58

Piotroski Rank

56 / 58

Muliplier Rank

29 / 58

Linearity 5 years - PSNL ranking 20 / 58

These are the competitors of Personalis in the industry Diagnostics & Research ranked by linearity 5 years
1. Qiagen QGEN
119.37
2. Co-Diagnostics CODX
100.26
3. Inotiv NOTV
41.71
4. Ortho Clinical Diagnostics Holdings OCDX
33.4
5. DarioHealth DRIO
31.71
6. CareDx CDNA
26.38
7. DexCom DXCM
25.28
8. Syneos Health SYNH
24.79
9. Fulgent Genetics FLGT
16.26
10. Heska HSKA
15.42
11. Exact Sciences EXAS
13.48
12. Pacific Biosciences of California PACB
12.73
13. Myriad Genetics MYGN
11.66
14. Charles River Laboratories CRL
10.92
15. Olink Holding OLK
8.53
16. Icon ICLR
8.39
17. Twist Bioscience TWST
7.97
18. Precipio PRPO
7.23
19. Guardant Health GH
6.9
20. Personalis PSNL
6.73
21. Aspira Womens Health AWH
5.9
22. PerkinElmer PKI
4.97
23. Trinity Biotech TRIB
4.91
24. IQVIA Holdings IQV
4.36
25. Agilent Technologies A
4.23
26. Danaher DHR
4.16
27. NeoGenomics NEO
4.03
28. IDEXX Laboratories IDXX
4.02
29. Psychemedics PMD
3.97
30. National Research NRC
3.91
31. Illumina ILMN
3.85
32. Sotera Health SHC
3.71
33. Mettler-Toledo MTD
3.7
34. Neogen NEOG
3.6
35. Enzo Biochem ENZ
3.59
36. Thermo Fisher Scientific TMO
3.33
37. Bioventus BVS
3.27
38. Anixa Biosciences ANIX
2.92
39. Exagen XGN
2.57
40. Sera Prognostics SERA
2.48
41. Interpace Biosciences IDXG
2.45
42. Waters WAT
2.4
43. Laboratory Corp of America Holdings LH
2.39
44. Neuronetics STIM
2.28
45. Quest Diagnostics DGX
2.26
46. Global Cord Blood CO
2.23
47. MDxHealth MDXH
1.92
48. MaxCyte MXCT
1.82
49. Biodesix BDSX
1.8
50. Prenetics Global PRE
1.72
51. bioAffinity Technologies BIAF
1.67
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Medpace Holdings MEDP
0.73
56. RadNet RDNT
0.63
57. Natera NTRA
0.61
58. Lantheus Holdings LNTH
0.31
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.